“…More recently, the 5th National Audit Project (NAP5) demonstrated an overall incidence of ~1:19,000 anaesthetics . The disparity between results and methodologies used has been extensively discussed, with Avidan and Sleigh commenting in an editorial that NAP5 ‘was reliant on sampling from the population of all GA survivors from 1946 to the present, who had not previously reported any intra‐operative recall, and who had also chanced to be exposed to the investigation team’ . Importantly, the associated NAP5 Activity Survey reported that only 2.8% of all general anaesthetics involved depth of anaesthesia (DOA) monitoring in the UK .…”